Home Data Calendar Blog

LNTH

Tables

		2024-09-30	2024-06-30	2024-03-31	2023-12-31	2023-09-30	2023-06-30	2023-03-31	2022-12-31	2022-09-30	2022-06-30	2022-03-31	2021-12-31	2021-09-30	2021-06-30	2021-03-31	2020-12-31	2020-09-30	2020-06-30	2020-03-31	2019-12-31	2019-09-30	2019-06-30	2019-03-31	2018-12-31	2018-09-30	2018-06-30	2018-03-31	2017-12-31	2017-09-30	2017-06-30	2017-03-31	2016-12-31	2016-09-30	2016-06-30	2016-03-31	2015-12-31	2015-09-30	2015-06-30	2015-03-31	2014-12-31	2014-09-30	2014-06-30	2014-03-31
Common Stock Value		0.71	0.71	0.71	0.70	0.70	0.70	0.70	0.69	0.69	0.69	0.69	0.68	0.68	0.68	0.67	0.67	0.67	0.67	0.40	0.39	0.39	0.39	0.39	0.39	0.39	0.38	0.38	0.38	0.38	0.37	0.37	0.37	0.36	0.30	0.30	0.30	0.30	0.30	NA	0.18	NA	NA	NA
Weighted Average Number Of Diluted Shares Outstanding		73.06	70.60	70.09	NA	70.05	71.01	67.75	NA	71.08	70.80	70.05	NA	67.62	67.50	67.71	NA	66.82	43.13	40.10	NA	40.29	40.24	39.79	NA	39.40	39.40	39.49	NA	39.12	38.90	38.60	NA	32.40	30.54	30.37	NA	30.76	18.90	18.40	NA	18.08	NA	NA
Weighted Average Number Of Shares Outstanding Basic		69.46	69.36	68.76	NA	68.44	68.37	67.75	NA	68.76	68.67	68.01	NA	67.62	67.50	67.09	NA	66.82	43.13	39.43	NA	39.12	38.97	38.60	NA	38.34	38.23	37.89	NA	37.39	37.23	36.89	NA	31.22	30.38	30.37	NA	30.36	18.90	18.08	NA	18.08	NA	NA
Earnings Per Share Basic		1.89	0.89	1.91	1.52	1.93	1.38	-0.04	-1.74	0.89	0.63	0.63	-0.60	-0.20	-0.39	0.13	-0.05	-0.10	-0.16	0.08	0.27	0.12	0.16	0.26	0.35	0.24	0.25	0.22	2.58	0.23	0.37	0.11	0.13	0.14	0.24	0.34	0.13	0.18	-1.29	0.02	NA	NA	NA	NA
Earnings Per Share Diluted		1.79	0.88	1.87	1.47	1.88	1.33	-0.04	-1.68	0.86	0.61	0.61	-0.60	-0.20	-0.39	0.13	-0.05	-0.10	-0.16	0.08	0.26	0.12	0.16	0.25	0.34	0.24	0.25	0.21	2.47	0.22	0.35	0.11	0.13	0.13	0.24	0.34	0.13	0.18	-1.29	0.02	NA	NA	NA	NA

		2024-09-30	2024-06-30	2024-03-31	2023-12-31	2023-09-30	2023-06-30	2023-03-31	2022-12-31	2022-09-30	2022-06-30	2022-03-31	2021-12-31	2021-09-30	2021-06-30	2021-03-31	2020-12-31	2020-09-30	2020-06-30	2020-03-31	2019-12-31	2019-09-30	2019-06-30	2019-03-31	2018-12-31	2018-09-30	2018-06-30	2018-03-31	2017-12-31	2017-09-30	2017-06-30	2017-03-31	2016-12-31	2016-09-30	2016-06-30	2016-03-31	2015-12-31	2015-09-30	2015-06-30	2015-03-31	2014-12-31	2014-09-30	2014-06-30	2014-03-31
Revenue From Contract With Customer Excluding Assessed Tax		378.73	394.09	369.98	354.00	319.95	321.70	300.78	263.17	239.29	223.72	208.88	129.56	102.07	101.06	92.51	94.15	88.54	66.01	90.70	89.35	85.78	85.70	86.51	86.27	88.90	85.57	82.63	81.24	79.94	88.84	81.36	74.35	73.06	77.97	76.47	71.20	74.12	73.31	74.82	76.97	75.68	75.61	73.34
Revenues		378.73	394.09	369.98	354.00	319.95	321.70	300.78	263.17	239.29	223.72	208.88	129.56	102.07	101.06	92.51	94.15	88.54	66.01	90.70	89.35	85.78	85.70	86.51	86.27	88.90	85.57	82.63	81.24	79.94	88.84	81.36	74.35	73.06	77.97	76.47	71.20	74.12	73.31	74.82	76.97	75.68	75.61	73.34
Cost Of Revenue		136.61	138.32	128.13	124.13	120.00	119.05	223.71	96.00	91.86	85.69	79.81	71.65	59.40	54.98	51.48	55.50	52.28	40.16	52.70	44.78	44.19	41.13	42.43	42.43	44.02	41.73	40.32	43.34	41.41	42.89	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
Cost Of Goods And Services Sold		136.61	138.32	128.13	124.13	120.00	119.05	223.71	96.00	91.86	85.69	79.81	71.65	59.40	54.98	51.48	55.50	52.28	40.16	52.70	44.78	44.19	41.13	42.43	42.43	44.02	41.73	40.32	43.34	41.41	42.89	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
Gross Profit		242.13	255.77	241.85	229.87	199.95	202.65	77.08	167.17	147.43	138.03	129.07	57.91	42.67	46.09	41.03	38.65	36.26	25.85	38.00	44.56	41.59	44.57	44.08	43.84	44.88	43.85	42.31	37.90	38.53	45.95	39.76	34.65	33.68	35.75	33.70	33.38	33.70	32.67	35.77	32.76	31.64	31.06	30.06
Research And Development Expense		24.15	60.60	48.02	16.82	14.45	15.90	30.53	272.23	12.52	14.73	12.20	11.29	11.25	12.06	10.36	12.64	11.68	4.42	4.05	4.43	4.86	5.79	4.93	4.55	4.32	4.21	3.99	3.98	3.55	5.24	5.35	3.71	2.85	2.61	3.04	3.07	2.46	2.64	6.20	4.71	3.05	2.69	NA
General And Administrative Expense		40.52	47.41	47.90	40.30	35.74	26.15	23.27	39.64	23.76	32.60	37.59	62.53	28.55	43.18	16.14	13.68	18.22	20.67	16.70	17.30	18.06	13.29	12.59	12.44	13.61	11.57	12.54	14.29	12.08	11.20	12.27	9.99	10.09	9.24	9.51	10.12	9.21	15.44	9.12	8.43	11.04	8.99	NA
Selling And Marketing Expense		43.72	45.03	45.55	35.26	37.40	36.46	32.62	26.98	25.41	27.49	20.35	19.42	17.20	17.63	14.17	12.86	11.61	6.30	10.13	10.39	10.15	10.95	10.40	9.91	10.48	12.13	10.64	10.42	10.07	11.60	10.21	8.69	8.71	9.84	9.31	7.81	8.63	9.23	9.07	7.89	8.33	9.40	NA
Operating Income Loss		133.74	102.73	106.64	137.49	112.36	124.14	-9.34	-171.68	85.74	63.20	58.92	-35.34	-14.33	-26.78	15.62	-0.53	-5.25	-5.54	7.12	12.44	8.52	14.54	16.17	16.94	16.48	15.93	15.14	9.21	12.82	17.90	11.93	12.14	12.60	14.18	17.67	12.39	13.41	5.36	11.38	11.73	9.22	9.98	NA
Allocated Share Based Compensation Expense		20.37	18.48	15.38	14.17	13.98	12.69	9.67	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
Income Tax Expense Benefit		45.02	22.30	40.20	35.02	28.00	29.56	-8.30	-57.06	21.78	18.99	14.94	-0.79	-6.42	-1.88	5.33	0.57	-1.08	0.31	2.19	-8.05	0.50	1.70	2.81	4.00	3.57	2.22	3.80	-85.85	0.80	0.57	0.79	0.88	0.02	0.25	0.39	1.06	0.74	1.18	-0.00	1.57	-0.06	0.87	NA
Net Income Loss		131.09	62.07	131.07	103.38	131.96	94.13	-2.81	-119.19	61.23	43.06	42.96	-40.22	-13.41	-26.66	9.01	-3.41	-6.39	-7.01	3.34	10.45	4.86	6.41	9.95	13.29	9.27	9.74	8.21	97.13	8.53	13.60	4.14	4.87	4.22	7.35	10.32	3.92	5.39	-24.42	0.38	0.23	-0.87	-1.64	-1.28
Comprehensive Income Net Of Tax		131.14	62.04	130.93	103.38	131.87	94.56	-2.93	-123.44	61.90	43.47	45.36	-39.56	-13.56	-26.42	9.82	-2.95	-6.29	-7.22	1.90	10.49	4.82	6.50	10.01	13.22	9.27	9.75	8.21	97.18	8.41	13.57	4.13	4.98	4.89	7.27	10.66	4.38	4.94	-24.44	0.02	-0.67	-1.54	-1.03	NA
Net Income Loss Available To Common Stockholders Basic		131.09	62.07	131.07	103.38	131.96	94.13	-2.81	-119.19	61.23	43.06	42.96	-40.22	-13.41	-26.66	9.01	NA	-6.39	-7.01	3.34	NA	4.86	6.41	9.95	13.29	9.27	9.74	8.21	97.13	8.53	13.60	4.14	4.87	4.22	7.35	10.32	3.92	5.39	-24.42	0.38	0.23	-0.87	-1.64	NA

		2024-09-30	2024-06-30	2024-03-31	2023-12-31	2023-09-30	2023-06-30	2023-03-31	2022-12-31	2022-09-30	2022-06-30	2022-03-31	2021-12-31	2021-09-30	2021-06-30	2021-03-31	2020-12-31	2020-09-30	2020-06-30	2020-03-31	2019-12-31	2019-09-30	2019-06-30	2019-03-31	2018-12-31	2018-09-30	2018-06-30	2018-03-31	2017-12-31	2017-09-30	2017-06-30	2017-03-31	2016-12-31	2016-09-30	2016-06-30	2016-03-31	2015-12-31	2015-09-30	2015-06-30	2015-03-31	2014-12-31	2014-09-30	2014-06-30	2014-03-31
Assets		2049.63	1939.83	1831.33	1651.15	1521.61	1337.72	1349.28	1321.26	1095.94	1013.82	933.17	863.78	847.82	857.80	843.45	869.82	879.59	879.70	404.12	405.92	402.41	390.25	443.91	439.83	424.82	401.80	392.59	383.86	281.02	267.88	249.56	255.90	254.97	259.27	249.26	242.38	236.13	233.55	NA	243.15	NA	NA	NA
Liabilities		869.92	913.15	885.79	835.26	822.85	785.08	903.77	874.11	457.89	446.49	417.32	399.35	348.47	349.66	315.33	355.62	366.01	364.11	285.73	291.32	301.24	298.00	360.69	368.83	369.31	357.27	358.93	360.57	358.94	355.06	350.72	362.41	376.12	425.63	423.48	427.67	426.28	429.13	NA	482.42	NA	NA	NA
Liabilities And Stockholders Equity		2049.63	1939.83	1831.33	1651.15	1521.61	1337.72	1349.28	1321.26	1095.94	1013.82	933.17	863.78	847.82	857.80	843.45	869.82	879.59	879.70	404.12	405.92	402.41	390.25	443.91	439.83	424.82	401.80	392.59	383.86	281.02	267.88	249.56	255.90	254.97	259.27	249.26	242.38	236.13	233.55	NA	243.15	NA	NA	NA
Stockholders Equity		1179.71	1026.68	945.54	815.89	698.76	552.64	445.52	447.15	638.05	567.33	515.85	464.44	499.34	508.14	528.12	514.21	513.58	515.58	118.40	114.60	101.17	92.25	83.21	71.00	55.51	44.53	33.66	23.29	-77.92	-87.18	-101.16	-106.52	-121.16	-166.37	-174.22	-185.29	-190.15	-195.58	NA	-239.27	NA	NA	NA

		2024-09-30	2024-06-30	2024-03-31	2023-12-31	2023-09-30	2023-06-30	2023-03-31	2022-12-31	2022-09-30	2022-06-30	2022-03-31	2021-12-31	2021-09-30	2021-06-30	2021-03-31	2020-12-31	2020-09-30	2020-06-30	2020-03-31	2019-12-31	2019-09-30	2019-06-30	2019-03-31	2018-12-31	2018-09-30	2018-06-30	2018-03-31	2017-12-31	2017-09-30	2017-06-30	2017-03-31	2016-12-31	2016-09-30	2016-06-30	2016-03-31	2015-12-31	2015-09-30	2015-06-30	2015-03-31	2014-12-31	2014-09-30	2014-06-30	2014-03-31
Assets Current		1295.71	1231.15	1148.80	1085.82	948.43	752.22	773.27	677.62	501.90	404.42	324.75	235.79	201.52	186.21	168.35	184.22	184.53	181.16	180.38	172.91	154.39	139.86	195.50	195.41	190.96	167.06	159.26	147.85	136.61	125.62	106.68	110.82	110.47	113.02	100.04	90.10	83.44	78.99	NA	81.23	NA	NA	NA
Cash And Cash Equivalents At Carrying Value		866.39	757.02	718.28	713.66	614.13	414.08	470.86	415.65	257.26	171.43	105.36	98.51	91.47	91.50	68.86	79.61	87.99	90.31	95.71	92.92	78.06	56.88	112.06	113.40	104.58	86.46	73.74	76.29	68.08	57.15	40.88	51.18	53.20	54.85	38.88	28.60	21.92	22.20	30.74	19.74	27.13	16.02	NA
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents		868.05	758.67	719.92	715.28	615.75	415.68	472.46	417.24	258.84	173.57	107.50	100.65	93.62	93.64	71.00	82.69	90.14	92.45	95.71	92.92	78.06	56.88	112.06	113.40	104.58	86.46	73.74	76.29	NA	NA	NA	51.18	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
Accounts Receivable Net Current		329.34	372.29	337.39	284.29	259.20	256.28	242.11	213.40	197.28	187.05	172.28	89.34	64.05	54.89	58.99	54.00	49.21	46.88	44.88	43.53	40.63	45.53	45.02	43.75	47.13	44.19	47.83	40.26	41.71	43.25	39.93	36.82	34.84	39.46	39.90	37.29	39.72	36.82	NA	41.54	NA	NA	NA
Inventory Net		70.83	70.52	69.76	64.03	56.46	51.80	42.16	35.48	34.79	33.96	34.25	35.13	33.95	31.72	30.36	35.74	37.62	35.33	30.81	29.18	30.60	32.41	32.04	33.02	34.57	31.47	32.09	26.08	23.03	21.15	19.79	17.64	16.06	14.43	15.54	15.62	16.58	15.40	NA	15.58	NA	NA	NA
Other Assets Current		22.00	24.16	16.21	16.68	11.48	22.91	10.95	13.09	12.57	11.99	12.86	12.82	12.04	8.10	10.14	9.62	9.71	8.63	8.97	7.28	5.10	5.04	6.37	5.24	4.67	4.92	5.60	5.22	3.79	4.07	6.08	5.18	6.37	4.28	5.72	3.95	5.21	4.58	NA	4.37	NA	NA	NA

		2024-09-30	2024-06-30	2024-03-31	2023-12-31	2023-09-30	2023-06-30	2023-03-31	2022-12-31	2022-09-30	2022-06-30	2022-03-31	2021-12-31	2021-09-30	2021-06-30	2021-03-31	2020-12-31	2020-09-30	2020-06-30	2020-03-31	2019-12-31	2019-09-30	2019-06-30	2019-03-31	2018-12-31	2018-09-30	2018-06-30	2018-03-31	2017-12-31	2017-09-30	2017-06-30	2017-03-31	2016-12-31	2016-09-30	2016-06-30	2016-03-31	2015-12-31	2015-09-30	2015-06-30	2015-03-31	2014-12-31	2014-09-30	2014-06-30	2014-03-31
Property Plant And Equipment Gross		286.68	270.54	257.88	253.72	244.36	230.92	227.51	222.29	218.11	214.34	208.94	205.69	202.44	201.22	197.92	196.58	211.09	208.29	191.26	208.15	203.41	200.79	197.42	190.63	179.71	177.64	176.56	189.27	187.89	183.11	179.43	176.69	151.47	NA	NA	144.68	NA	NA	NA	NA	NA	NA	NA
Accumulated Depreciation Depletion And Amortization Property Plant And Equipment		117.17	112.38	107.79	107.02	104.06	100.94	100.03	100.13	97.29	95.33	91.99	88.92	86.00	82.73	79.54	76.41	88.71	85.38	82.64	91.66	89.88	87.68	85.21	82.74	80.31	80.82	82.79	96.27	93.38	91.25	87.34	82.50	72.17	70.97	69.02	67.26	67.53	65.94	NA	61.43	NA	NA	NA
Amortization Of Intangible Assets		11.90	10.20	9.90	11.30	11.70	12.40	11.10	8.30	8.30	8.30	8.30	8.40	8.40	6.10	4.70	4.70	4.80	0.90	0.40	0.40	0.50	0.50	NA	NA	NA	NA	NA	NA	NA	NA	NA	1.20	1.30	1.30	1.30	1.50	1.50	1.50	1.50	1.90	1.90	1.90	NA
Property Plant And Equipment Net		169.51	158.16	150.09	146.70	140.29	129.98	127.48	122.17	120.83	119.00	116.96	116.77	116.44	118.49	118.38	120.17	122.38	122.90	108.61	116.50	113.53	113.12	112.21	107.89	99.41	96.82	93.78	93.00	94.52	91.86	92.09	94.19	84.98	84.42	85.32	86.52	92.39	92.87	NA	96.01	NA	NA	NA
Goodwill		61.19	61.19	61.19	61.19	61.19	61.19	61.19	61.19	61.19	61.19	61.19	61.19	61.19	61.19	61.19	58.63	57.77	57.77	15.71	15.71	15.71	15.71	15.71	15.71	15.71	15.71	15.71	15.71	15.71	15.71	15.71	15.71	15.71	15.71	15.71	15.71	15.71	15.71	NA	15.71	NA	NA	NA
Intangible Assets Net Excluding Goodwill		173.61	172.24	142.05	151.99	163.29	221.00	219.86	315.29	323.59	331.90	340.20	348.51	356.88	365.26	371.33	376.01	384.75	389.51	NA	7.34	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
Finite Lived Intangible Assets Net		173.61	172.24	142.05	151.99	163.29	221.00	219.86	299.64	307.95	316.26	324.56	332.87	341.24	349.62	222.89	227.57	233.85	238.61	6.93	7.34	7.79	8.24	8.69	9.13	9.73	10.41	11.11	11.80	12.64	13.46	14.29	15.12	16.41	17.95	19.23	20.50	22.49	24.10	NA	27.19	NA	NA	NA
Other Assets Noncurrent		46.18	49.49	51.34	55.26	56.21	39.13	33.61	34.35	41.63	42.16	42.20	38.76	45.29	61.87	61.36	60.63	60.82	60.92	22.04	21.63	33.25	34.15	32.04	30.23	29.65	29.77	29.08	28.49	21.54	21.22	20.79	20.06	19.73	20.04	20.34	20.41	20.12	19.78	NA	20.58	NA	NA	NA

		2024-09-30	2024-06-30	2024-03-31	2023-12-31	2023-09-30	2023-06-30	2023-03-31	2022-12-31	2022-09-30	2022-06-30	2022-03-31	2021-12-31	2021-09-30	2021-06-30	2021-03-31	2020-12-31	2020-09-30	2020-06-30	2020-03-31	2019-12-31	2019-09-30	2019-06-30	2019-03-31	2018-12-31	2018-09-30	2018-06-30	2018-03-31	2017-12-31	2017-09-30	2017-06-30	2017-03-31	2016-12-31	2016-09-30	2016-06-30	2016-03-31	2015-12-31	2015-09-30	2015-06-30	2015-03-31	2014-12-31	2014-09-30	2014-06-30	2014-03-31
Liabilities Current		784.08	263.29	237.20	187.35	176.60	154.04	276.39	247.70	235.98	219.02	177.66	90.50	76.90	73.83	64.59	80.50	82.00	76.34	61.96	66.11	59.59	53.36	42.77	52.76	54.58	43.25	45.40	46.75	46.09	43.06	39.13	43.84	39.12	34.09	31.48	35.72	34.32	37.55	NA	48.53	NA	NA	NA
Long Term Debt Current		564.71	0.87	0.73	0.82	0.70	0.38	0.42	0.35	15.37	14.06	12.88	11.64	10.36	10.37	10.25	20.70	18.14	17.14	10.14	10.14	10.17	10.14	2.85	2.75	2.75	2.75	2.75	2.75	2.75	2.75	2.75	3.65	3.65	3.65	3.65	3.65	3.65	3.65	NA	NA	NA	NA	NA
Accounts Payable Current		44.91	49.77	37.52	41.19	37.08	38.86	30.80	20.56	30.14	21.15	22.38	20.79	20.51	21.47	19.10	16.28	24.07	16.30	18.98	18.61	16.49	17.15	15.32	17.95	20.36	15.31	21.01	17.46	18.76	17.67	17.57	18.94	13.62	12.78	12.98	11.66	10.70	14.20	NA	15.66	NA	NA	NA
Other Accrued Liabilities Current		14.83	16.80	54.69	15.16	22.56	11.16	50.38	25.52	11.14	11.01	7.50	5.35	NA	NA	NA	6.13	NA	NA	NA	2.10	NA	NA	NA	2.04	NA	NA	NA	2.75	NA	NA	NA	1.94	1.14	0.60	0.74	0.69	0.53	0.74	NA	0.70	NA	NA	NA

		2024-09-30	2024-06-30	2024-03-31	2023-12-31	2023-09-30	2023-06-30	2023-03-31	2022-12-31	2022-09-30	2022-06-30	2022-03-31	2021-12-31	2021-09-30	2021-06-30	2021-03-31	2020-12-31	2020-09-30	2020-06-30	2020-03-31	2019-12-31	2019-09-30	2019-06-30	2019-03-31	2018-12-31	2018-09-30	2018-06-30	2018-03-31	2017-12-31	2017-09-30	2017-06-30	2017-03-31	2016-12-31	2016-09-30	2016-06-30	2016-03-31	2015-12-31	2015-09-30	2015-06-30	2015-03-31	2014-12-31	2014-09-30	2014-06-30	2014-03-31
Long Term Debt And Capital Lease Obligations		0.61	563.19	562.47	561.67	560.58	559.24	558.54	557.71	152.06	155.66	159.37	163.12	166.74	169.25	NA	197.70	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
Other Liabilities Noncurrent		61.99	63.54	63.11	63.32	62.85	49.07	46.21	46.16	46.49	49.62	58.78	124.89	89.64	91.79	64.86	63.39	65.38	64.16	29.04	28.40	42.72	43.70	42.74	40.79	39.32	38.48	37.85	38.01	37.18	36.17	35.63	34.74	33.72	34.05	34.24	33.95	33.52	32.80	NA	33.60	NA	NA	NA
Operating Lease Liability Noncurrent		53.91	54.12	54.12	54.45	54.42	31.25	24.79	25.44	15.35	15.78	16.21	16.55	16.39	NA	NA	17.50	NA	NA	NA	0.81	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA

		2024-09-30	2024-06-30	2024-03-31	2023-12-31	2023-09-30	2023-06-30	2023-03-31	2022-12-31	2022-09-30	2022-06-30	2022-03-31	2021-12-31	2021-09-30	2021-06-30	2021-03-31	2020-12-31	2020-09-30	2020-06-30	2020-03-31	2019-12-31	2019-09-30	2019-06-30	2019-03-31	2018-12-31	2018-09-30	2018-06-30	2018-03-31	2017-12-31	2017-09-30	2017-06-30	2017-03-31	2016-12-31	2016-09-30	2016-06-30	2016-03-31	2015-12-31	2015-09-30	2015-06-30	2015-03-31	2014-12-31	2014-09-30	2014-06-30	2014-03-31
Stockholders Equity		1179.71	1026.68	945.54	815.89	698.76	552.64	445.52	447.15	638.05	567.33	515.85	464.44	499.34	508.14	528.12	514.21	513.58	515.58	118.40	114.60	101.17	92.25	83.21	71.00	55.51	44.53	33.66	23.29	-77.92	-87.18	-101.16	-106.52	-121.16	-166.37	-174.22	-185.29	-190.15	-195.58	NA	-239.27	NA	NA	NA
Common Stock Value		0.71	0.71	0.71	0.70	0.70	0.70	0.70	0.69	0.69	0.69	0.69	0.68	0.68	0.68	0.67	0.67	0.67	0.67	0.40	0.39	0.39	0.39	0.39	0.39	0.39	0.38	0.38	0.38	0.38	0.37	0.37	0.37	0.36	0.30	0.30	0.30	0.30	0.30	NA	0.18	NA	NA	NA
Additional Paid In Capital Common Stock		797.43	775.54	756.44	757.73	743.97	729.73	717.16	715.88	708.34	699.53	691.52	685.47	680.82	676.06	669.62	665.53	661.96	657.67	253.53	251.64	248.69	244.60	242.07	239.87	237.59	235.88	234.76	232.96	228.93	228.08	227.68	226.46	216.81	176.54	175.96	175.55	175.07	174.58	NA	106.70	NA	NA	NA
Retained Earnings Accumulated Deficit		457.74	326.64	264.57	133.50	30.12	-101.83	-195.97	-193.16	-73.97	-135.21	-178.26	-221.22	-181.01	-167.59	-140.94	-149.95	-146.53	-140.15	-133.14	-136.47	-146.92	-151.78	-158.19	-168.14	-181.43	-190.70	-200.45	-209.01	-306.14	-314.67	-328.26	-332.40	-337.27	-341.49	-348.84	-359.16	-363.08	-368.46	NA	-344.41	NA	NA	NA
Accumulated Other Comprehensive Income Loss Net Of Tax		-1.17	-1.21	-1.18	-1.04	-1.03	-0.95	-1.38	-1.26	2.99	2.32	1.91	-0.48	-1.14	-1.00	-1.24	-2.05	-2.51	-2.61	-2.39	-0.96	-1.00	-0.96	-1.05	-1.11	-1.03	-1.03	-1.03	-1.03	-1.09	-0.97	-0.95	-0.95	-1.06	-1.73	-1.65	-1.99	-2.45	-2.00	NA	-1.63	NA	NA	NA
Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value		20.37	18.48	15.38	NA	13.98	12.69	9.67	NA	8.10	7.41	5.62	NA	3.87	4.59	3.32	NA	3.99	3.38	3.08	NA	3.42	3.36	2.72	NA	2.41	2.22	1.80	NA	NA	NA	NA	0.66	0.88	0.58	0.41	0.48	0.59	NA	NA	NA	NA	NA	NA

		2024-09-30	2024-06-30	2024-03-31	2023-12-31	2023-09-30	2023-06-30	2023-03-31	2022-12-31	2022-09-30	2022-06-30	2022-03-31	2021-12-31	2021-09-30	2021-06-30	2021-03-31	2020-12-31	2020-09-30	2020-06-30	2020-03-31	2019-12-31	2019-09-30	2019-06-30	2019-03-31	2018-12-31	2018-09-30	2018-06-30	2018-03-31	2017-12-31	2017-09-30	2017-06-30	2017-03-31	2016-12-31	2016-09-30	2016-06-30	2016-03-31	2015-12-31	2015-09-30	2015-06-30	2015-03-31	2014-12-31	2014-09-30	2014-06-30	2014-03-31
Net Cash Provided By Used In Operating Activities		175.06	84.72	127.24	112.29	116.74	-32.27	108.50	105.35	93.57	72.60	10.26	13.89	4.34	25.87	9.82	0.57	8.57	-2.16	9.41	22.42	26.44	21.05	10.47	17.31	24.28	20.28	-0.67	13.09	15.60	20.57	5.52	12.78	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
Net Cash Provided By Used In Investing Activities		-67.80	-45.09	-106.53	-12.07	83.22	-20.70	-44.51	-264.72	-6.09	-4.34	-1.39	-4.54	-2.42	-2.66	13.30	-3.79	-3.74	5.31	-2.70	-4.74	-3.34	-3.43	-10.55	-7.37	-5.00	-5.63	-1.14	-5.95	-3.29	-2.50	-4.56	-2.36	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
Net Cash Provided By Used In Financing Activities		1.87	0.10	-16.84	-0.45	0.11	-4.05	-8.67	317.84	-1.96	-2.01	-2.18	-2.10	-1.73	-0.71	-34.79	-4.37	-7.27	-6.49	-3.73	-2.82	-1.90	-72.93	-1.23	-0.93	-1.22	-1.81	-0.70	1.15	-1.52	-1.83	-11.25	-12.26	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA

		2024-09-30	2024-06-30	2024-03-31	2023-12-31	2023-09-30	2023-06-30	2023-03-31	2022-12-31	2022-09-30	2022-06-30	2022-03-31	2021-12-31	2021-09-30	2021-06-30	2021-03-31	2020-12-31	2020-09-30	2020-06-30	2020-03-31	2019-12-31	2019-09-30	2019-06-30	2019-03-31	2018-12-31	2018-09-30	2018-06-30	2018-03-31	2017-12-31	2017-09-30	2017-06-30	2017-03-31	2016-12-31	2016-09-30	2016-06-30	2016-03-31	2015-12-31	2015-09-30	2015-06-30	2015-03-31	2014-12-31	2014-09-30	2014-06-30	2014-03-31
Net Cash Provided By Used In Operating Activities		175.06	84.72	127.24	112.29	116.74	-32.27	108.50	105.35	93.57	72.60	10.26	13.89	4.34	25.87	9.82	0.57	8.57	-2.16	9.41	22.42	26.44	21.05	10.47	17.31	24.28	20.28	-0.67	13.09	15.60	20.57	5.52	12.78	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
Net Income Loss		131.09	62.07	131.07	103.38	131.96	94.13	-2.81	-119.19	61.23	43.06	42.96	-40.22	-13.41	-26.66	9.01	-3.41	-6.39	-7.01	3.34	10.45	4.86	6.41	9.95	13.29	9.27	9.74	8.21	97.13	8.53	13.60	4.14	4.87	4.22	7.35	10.32	3.92	5.39	-24.42	0.38	0.23	-0.87	-1.64	-1.28
Increase Decrease In Accounts Receivable		-43.14	32.59	55.44	25.59	3.97	14.40	24.68	16.43	11.04	15.84	85.16	25.38	9.27	-3.90	2.35	6.76	2.79	-3.84	1.75	2.92	-4.83	0.71	1.04	-3.22	2.98	-3.59	7.82	-1.20	-1.76	3.23	3.13	2.13	-3.08	-0.62	2.63	0.80	3.47	-1.50	-2.76	1.18	-1.35	NA	NA
Increase Decrease In Inventories		-0.87	-0.52	8.49	10.22	6.74	12.13	7.12	2.84	2.65	0.38	1.63	2.92	2.51	2.00	-3.89	-1.13	2.82	4.68	2.10	-1.27	-1.09	0.83	-0.47	-1.14	3.12	0.14	6.58	3.26	2.13	1.80	2.43	1.97	2.18	-0.83	0.30	0.17	1.97	-0.48	0.95	-0.83	0.44	NA	NA
Increase Decrease In Accounts Payable		-5.72	10.34	-3.46	5.04	-2.04	7.44	6.75	-8.11	9.27	-2.37	1.51	0.65	-1.11	1.78	4.11	-7.99	7.21	-2.54	-0.91	1.78	-1.43	1.42	1.46	-5.09	5.10	-5.06	2.16	0.87	-1.04	-0.43	1.20	3.02	1.21	-0.60	2.07	1.08	-2.87	0.88	-0.77	-1.08	0.96	NA	NA
Share Based Compensation		20.37	18.48	15.38	14.17	13.98	12.69	9.67	8.12	8.10	7.41	5.62	4.16	3.87	4.59	3.32	3.62	3.99	3.38	3.08	2.99	3.42	3.36	2.72	2.30	2.41	2.22	1.80	2.16	1.66	1.16	0.94	0.66	0.88	0.58	0.41	0.48	0.59	0.66	0.28	0.25	0.25	0.25	NA
Amortization Of Financing Costs		1.07	1.07	1.07	1.07	1.07	1.07	1.08	NA	NA	NA	NA	0.25	0.24	0.25	-0.06	-0.08	-0.14	0.17	0.17	0.17	0.17	0.32	0.32	0.32	0.32	0.32	0.32	0.33	0.34	0.34	0.36	0.37	0.30	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA

		2024-09-30	2024-06-30	2024-03-31	2023-12-31	2023-09-30	2023-06-30	2023-03-31	2022-12-31	2022-09-30	2022-06-30	2022-03-31	2021-12-31	2021-09-30	2021-06-30	2021-03-31	2020-12-31	2020-09-30	2020-06-30	2020-03-31	2019-12-31	2019-09-30	2019-06-30	2019-03-31	2018-12-31	2018-09-30	2018-06-30	2018-03-31	2017-12-31	2017-09-30	2017-06-30	2017-03-31	2016-12-31	2016-09-30	2016-06-30	2016-03-31	2015-12-31	2015-09-30	2015-06-30	2015-03-31	2014-12-31	2014-09-30	2014-06-30	2014-03-31
Net Cash Provided By Used In Investing Activities		-67.80	-45.09	-106.53	-12.07	83.22	-20.70	-44.51	-264.72	-6.09	-4.34	-1.39	-4.54	-2.42	-2.66	13.30	-3.79	-3.74	5.31	-2.70	-4.74	-3.34	-3.43	-10.55	-7.37	-5.00	-5.63	-1.14	-5.95	-3.29	-2.50	-4.56	-2.36	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA

		2024-09-30	2024-06-30	2024-03-31	2023-12-31	2023-09-30	2023-06-30	2023-03-31	2022-12-31	2022-09-30	2022-06-30	2022-03-31	2021-12-31	2021-09-30	2021-06-30	2021-03-31	2020-12-31	2020-09-30	2020-06-30	2020-03-31	2019-12-31	2019-09-30	2019-06-30	2019-03-31	2018-12-31	2018-09-30	2018-06-30	2018-03-31	2017-12-31	2017-09-30	2017-06-30	2017-03-31	2016-12-31	2016-09-30	2016-06-30	2016-03-31	2015-12-31	2015-09-30	2015-06-30	2015-03-31	2014-12-31	2014-09-30	2014-06-30	2014-03-31
Net Cash Provided By Used In Financing Activities		1.87	0.10	-16.84	-0.45	0.11	-4.05	-8.67	317.84	-1.96	-2.01	-2.18	-2.10	-1.73	-0.71	-34.79	-4.37	-7.27	-6.49	-3.73	-2.82	-1.90	-72.93	-1.23	-0.93	-1.22	-1.81	-0.70	1.15	-1.52	-1.83	-11.25	-12.26	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA

		2024-09-30	2024-06-30	2024-03-31	2023-12-31	2023-09-30	2023-06-30	2023-03-31	2022-12-31	2022-09-30	2022-06-30	2022-03-31	2021-12-31	2021-09-30	2021-06-30	2021-03-31	2020-12-31	2020-09-30	2020-06-30	2020-03-31	2019-12-31	2019-09-30	2019-06-30	2019-03-31	2018-12-31	2018-09-30	2018-06-30	2018-03-31	2017-12-31	2017-09-30	2017-06-30	2017-03-31	2016-12-31	2016-09-30	2016-06-30	2016-03-31	2015-12-31	2015-09-30	2015-06-30	2015-03-31	2014-12-31	2014-09-30	2014-06-30	2014-03-31
Revenues		378.73	394.09	369.98	354.00	319.95	321.70	300.78	263.17	239.29	223.72	208.88	129.56	102.07	101.06	92.51	94.15	88.54	66.01	90.70	89.35	85.78	85.70	86.51	86.27	88.90	85.57	82.63	81.24	79.94	88.84	81.36	74.35	73.06	77.97	76.47	71.20	74.12	73.31	74.82	76.97	75.68	75.61	73.34
Revenue From Contract With Customer Excluding Assessed Tax		378.73	394.09	369.98	354.00	319.95	321.70	300.78	263.17	239.29	223.72	208.88	129.56	102.07	101.06	92.51	94.15	88.54	66.01	90.70	89.35	85.78	85.70	86.51	86.27	88.90	85.57	82.63	81.24	79.94	88.84	81.36	74.35	73.06	77.97	76.47	71.20	74.12	73.31	74.82	76.97	75.68	75.61	73.34
Definity		76.97	78.10	76.56	73.08	67.34	70.53	68.82	63.62	60.74	62.31	58.33	59.31	57.64	59.84	55.97	60.73	55.43	40.37	56.79	59.37	52.40	54.63	51.11	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
Licenseand Royalty Revenues		4.13	1.33	0.66	16.78	0.44	7.62	8.53	7.29	5.93	5.94	28.87	6.76	5.39	7.50	5.19	5.26	4.88	1.08	0.49	NA	NA	NA	0.53	0.53	0.58	0.57	0.56	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
Other Precision Diagnostics		6.28	5.83	5.93	5.98	5.74	5.45	5.81	6.02	6.17	5.36	5.26	5.68	7.56	6.74	6.98	8.04	8.59	7.14	13.06	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
Other Radiopharmaceutical Oncology		0.00	0.00	0.38	0.75	0.85	0.82	0.72	0.92	0.93	0.93	1.33	0.27	1.17	2.54	1.50	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
PYLARIFY		259.76	273.25	258.87	229.88	215.43	210.52	195.47	160.64	143.75	130.23	92.78	35.42	7.72	0.27	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
Radiopharmaceutical Oncology		259.76	273.25	259.25	230.63	216.28	211.34	196.19	161.56	144.68	131.16	94.10	35.68	8.89	2.81	1.50	2.55	3.32	2.18	1.97	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
Strategic Partnerships And Other		15.25	8.72	6.51	22.79	7.32	12.78	8.98	7.24	5.60	5.45	28.58	6.84	5.30	7.90	5.25	5.30	5.16	0.89	0.40	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
Techne Lite		20.48	28.19	21.71	21.52	23.27	21.59	20.99	24.73	22.09	19.44	22.61	22.04	22.68	23.77	22.80	22.75	21.49	18.91	23.10	20.59	21.75	20.11	24.14	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
Total Precision Diagnostics		103.73	112.11	104.21	100.58	96.35	97.58	95.62	94.37	89.01	87.11	86.20	87.04	87.88	90.36	85.75	86.30	80.06	62.93	88.34	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
Product		374.60	392.76	369.31	337.22	319.51	314.08	292.26	255.88	233.37	217.78	180.01	122.80	96.68	93.56	87.32	NA	83.66	64.93	90.21	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA

Plots across concepts

Line plots across dimensions of each concept